In dormant colorectal cancer cells, β-catenin and NF-κB are confined in the cytoplasm, and treatment with PI3K inhibitor results to nuclear translocation of NF-κB and membrane retention of β-catenin. Here, NFKB1 is linked to colorectal cancer.